✦ LIBER ✦

Toxicity of ethylene chlorohydrin II: Subacute toxicity and special tests

✍ Scribed by W. H. Lawrence; K. Itoh; J. E. Turner; J. Autian

Publisher: John Wiley and Sons
Year: 1971
Tongue: English
Weight: 803 KB
Volume: 60
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600600810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity of ethylene chlorohydrin I: Acu

Toxicity of ethylene chlorohydrin I: Acute toxicity studies

✍ W. H. Lawrence; J. E. Turner; J. Autian 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

Observations on the chemical and biologi

Observations on the chemical and biological testing of pyrethrum extracts and the relative toxicity of pyrethiuns I and II

✍ Green, R. C. ;Pohl, W. ;Iresadern, F. H. ;West, T. F. 📂 Article 📅 1942 🏛 Wiley (John Wiley & Sons) ⚖ 510 KB

Poaaille comyoticd glyzcriiu o j 1Ac. Anlurctic whale oil (% mof.) \no10 Frnction . . . . . . . . . . A B C D fnt dGlyceridcs (yo mol.) .

Disturbances to metal partitioning durin

Disturbances to metal partitioning during toxicity testing of iron(II)-rich estuarine pore waters and whole sediments

✍ Stuart L. Simpson; Graeme E. Batley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Metal partitioning is altered when suboxic estuarine sediments containing Fe(II)‐rich pore waters are disturbed during collection, preparation, and toxicity testing. Experiments with model Fe(II)‐rich pore waters demonstrated the rates at which adsorptive losses of Cd, Cu, Ni, Mn, Pb, a

In vivo rodent erythrocyte micronucleus

In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring

✍ Makoto Hayashi; James T. MacGregor; David G. Gatehouse; Ilse-Dore Adler; David H 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

priate reference samples that have been obtained from a separate experiment. For studies in rats or mice, treatment/sampling regimens should include treatment at intervals of no more than 24 hr (unless the test article has a half-life of more than 24 hr) with sampling of bone marrow or blood, respec